Skip to main content

Written question asked by Freddie van Mierlo (Liberal Democrat) on Monday, 5 January 2026, in the House of Commons. It was due for an answer on Wednesday, 7 January 2026. It was answered by Ashley Dalton (Labour) on Thursday, 15 January 2026 on behalf of the Department of Health and Social Care.


Leukaemia: Blood Tests

Question

To ask the Secretary of State for Health and Social Care, whether he is taking steps to ensure that all patients with suspected leukaemia symptoms can access a full blood count test within 48 hours, as recommended by the NICE NG12 guidelines.

Answer

The Department is determined to take all the necessary steps to improve early diagnosis for all cancers, including blood cancers such as leukaemia.

To accomplish this, the National Health Service is implementing non-specific symptom pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type. Blood cancers are one of the most common cancer types diagnosed through these pathways.

The National Institute for Health and Care Excellence (NICE) has a guideline on suspected cancer called ‘recognition and referral’ which aim to support the identification of children, young people and adults with symptoms that could be caused by cancer’. The guideline provides guidance on appropriate investigations in primary care, and the selection of people to refer for a specialist opinion. The guideline recommends that people with specific symptoms should be offered a very urgent full blood count to assess for leukaemia. Local NHS organisations are expected to take NICE guidelines fully into account in ensuring that their services meet the needs of their local populations. The NHS is held to account to deliver guidelines, which include all NICE directions, at local and regional level.

The National Cancer Plan for England will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and ongoing care, as well as prevention. The plan will seek to improve every aspect of cancer care to better the experience and outcomes for all patient groups, including leukaemia patients.


Secondary information

Type
Written question
Reference
103089
Session
2024-26
Subjects
Leukaemia Blood tests
Link
View this Written question on www.parliament.uk